This stock attracted to me due to the fact that there is a built-in revenue stream from royalties from several different approved drugs and manufacturers (Biogen-Idec, Lilly, Genentech/Roche), with more in the pipeline. My only concern is that with… More
No way this guys will have good times soon. The fundamentals talk by themselves:Who will by a company with a P/B of 16x, have a ROE in the last 5y of -11, a P/S of 3,63x? Maybe you are looking for the 62,87% of Dividend Yield (Trailing 12mo.). But… More